These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3117704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Smith S, Waters V, Jahnke N, Ratjen F.
    Cochrane Database Syst Rev; 2020 Jun 10; 6(6):CD009528. PubMed ID: 32520436
    [Abstract] [Full Text] [Related]

  • 3. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2015 Mar 05; (3):CD009528. PubMed ID: 25741986
    [Abstract] [Full Text] [Related]

  • 4. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009528. PubMed ID: 23152277
    [Abstract] [Full Text] [Related]

  • 5. Changes in strategies for optimal antibacterial therapy in cystic fibrosis.
    Ratjen F.
    Int J Antimicrob Agents; 2001 Feb 14; 17(2):93-6. PubMed ID: 11165111
    [Abstract] [Full Text] [Related]

  • 6. Bacteriological effects of anti-Pseudomonas aeruginosa chemotherapy in cystic fibrosis.
    Bauernfeind A, Emminger G, Hörl G, Ott S, Przyklenk B, Weisslein-Pfister C.
    Infection; 1987 Feb 14; 15(5):403-6. PubMed ID: 3121519
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic therapy in cystic fibrosis. Evaluation of efficacy.
    Levy J.
    Chest; 1988 Aug 14; 94(2 Suppl):150S-156S. PubMed ID: 3135160
    [Abstract] [Full Text] [Related]

  • 8. [Antibiotic therapy of cystic fibrosis in children].
    Kapranov NI, Shabalova LA, Kashirskaia NIu, SimonovaO OI, Voronkova AIu, Osipova IA, Semykin SIu, Polikarpova SV, Postnikov SS.
    Antibiot Khimioter; 2001 Aug 14; 46(2):26-32. PubMed ID: 11544748
    [Abstract] [Full Text] [Related]

  • 9. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M.
    J Antimicrob Chemother; 1983 Jul 14; 12 Suppl A():297-311. PubMed ID: 6311788
    [Abstract] [Full Text] [Related]

  • 10. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D, Stableforth D.
    Drugs; 2000 Nov 14; 60(5):1053-64. PubMed ID: 11129122
    [Abstract] [Full Text] [Related]

  • 11. Oral anti-pseudomonal antibiotics for cystic fibrosis.
    Remmington T, Jahnke N, Harkensee C.
    Cochrane Database Syst Rev; 2007 Jul 18; (3):CD005405. PubMed ID: 17636796
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management.
    Høiby N, Koch C.
    Thorax; 1990 Nov 18; 45(11):881-4. PubMed ID: 2256020
    [No Abstract] [Full Text] [Related]

  • 13. Pseudomonas aeruginosa in cystic fibrosis patients with c.1652G›A (G551D)-CFTR treated with ivacaftor-Changes in microbiological parameters.
    Millar BC, McCaughan J, Rendall JC, Downey DG, Moore JE.
    J Clin Pharm Ther; 2018 Feb 18; 43(1):92-100. PubMed ID: 29293275
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Balke B, Hogardt M, Schmoldt S, Hoy L, Weissbrodt H, Häussler S.
    Eur J Clin Microbiol Infect Dis; 2006 Jan 18; 25(1):25-30. PubMed ID: 16402226
    [Abstract] [Full Text] [Related]

  • 15. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
    Taccetti G, Campana S, Festini F, Mascherini M, Döring G.
    Eur Respir J; 2005 Sep 18; 26(3):458-61. PubMed ID: 16135728
    [Abstract] [Full Text] [Related]

  • 16. [Antibiotic treatment of cystic fibrosis exacerbations].
    Dumcius S.
    Medicina (Kaunas); 2003 Sep 18; 39(3):221-4. PubMed ID: 12695633
    [Abstract] [Full Text] [Related]

  • 17. Are antipseudomonal antibiotics really beneficial in acute respiratory exacerbations of cystic fibrosis?
    Wolter JM, Bowler SD, McCormack JG.
    Aust N Z J Med; 1999 Feb 18; 29(1):15-21. PubMed ID: 10200808
    [Abstract] [Full Text] [Related]

  • 18. Value of inhaled antibiotics in cystic fibrosis patients.
    Wunderlich P, Paul KD, Wehner J.
    Acta Univ Carol Med (Praha); 1990 Feb 18; 36(1-4):34-6. PubMed ID: 2130713
    [Abstract] [Full Text] [Related]

  • 19. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Greally P, Whitaker P, Peckham D.
    Curr Med Res Opin; 2012 Jun 18; 28(6):1059-67. PubMed ID: 22401602
    [Abstract] [Full Text] [Related]

  • 20. Antibacterial therapy in cystic fibrosis. A review of the literature published between 1980 and February 1987.
    Michel BC.
    Chest; 1988 Aug 18; 94(2 Suppl):129S-140S. PubMed ID: 3293939
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.